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Summary. The blood flow of tumours growing in rat mammary glands previously
exposed to 1500 R X-rays was 52% that of same-sized tumours in unirradiated host
tissue. About 2 months after irradiation, the blood flow of the mammary gland was
raised and that of the skin was unchanged, compared with the corresponding un-
irradiated tissue. Tumours growing in preirradiated and unirradiated mammary
glands responded similarly to bolus injections of noradrenaline, angiotensin II, and
isoprenaline. The responses of the irradiated tissues to these drugs were, however,
not always the same as those of the corresponding unirradiated tissues. Exposure of
the lungs to,-. 1500 R X-rays made the animals uniquely sensitive to bolusinjections
of noradrenaline and angiotensin II.
WHEN TUMOUR TISSUE is transplanted
into previously irradiated host tissue, the
tumours which develop grow more slowly
than when similar tissue is grafted in
unirradiated sites. This phenomenon, re-
ferred to as the "tumour bed effect"
(TBE), was first described by Frankl and
Kimball (1914) and has since been further
investigated (Summers, Clifton and Ver-
mund, 1964; Hewitt and Blake, 1968;
Urano and Suit, 1971).
The TBE is maximized by 1000 R
(Hewitt and Blake, 1968) to 2000 R
(Summers et al., 1964) and remains
undiminished for at least 254 days after
irradiation (Summers etal., 1964). Boththe
TD50 value (i.e., the number of cells
required to produce tumours in 50% ofthe
inoculation sites; Urano and Suit, 1971;
Clifton and Jirtle, 1975) and the latency
(i.e. the time required for a tumour to
become palpable; Hewitt and Blake, 1968)
are unchanged by preirradiation of the
transplantation site. Further, the pro-
liferation rate of tumour cells in the
grossly "viable" portions of tumours
remains constant with growth, and is
independent of whether the tumour is
growing in preirradiated or unirradiated
host tissue (Clifton and Jirtle, 1975). Thus
the TBE is not due either to an initial
increased loss of the injected tumour cells
from the graft site, or to a decreased
proliferation rate ofthe remaining tumour
cells. Rather, the data indicate that the
reduction in tumour growth is due
primarily to a reduced capacity of the
irradiated endothelial cells in the normal
tissue to provide sufficient new vascular
space to support rapid tumour growth.
Irradiation of normal tissue before
transplantation not only "kills" endothel-
ial cells reproductively (Reinhold and
Buisman, 1973), but also causes morpho-
logical changes in the vessels (Sams, 1963;
Lindop, Jones and Bakowska, 1970;
Takahashi and Kallman, 1977). The extent
to which such vascular changes alter
subsequent tissue blood flow has not been
thoroughlyinvestigated. Ifbloodflowtothe
tumour is reduced by preirradiation ofthe
normal tissue in which it is growing, it
Address for correspondence: Randy Jirtle, Duke University Medical Center, Department of Radiology,
Box 3433, Durham, N.C. 27710.R. JIRTLE, J. H. G. RANKIN AND K. H. CLIFTON
could reduce the rate of tumour growth.
In addition, radiation damage to vascular
smooth muscle could impair the ability of
the vasculature to respond to vasoactive
drugs. A recently described technique for
measuring the blood flow to both normal
and malignant tissue in conscious mini-
mally disturbed rats (Jirtle, Clifton and
Rankin, 1978a) was used to investigate
these problems.
MATERIALS AND METHODS
Animal and tumour system.-Isogeneic
female W/Fu rats weighing 240 g were
housed in hanging cages in a temperature-
controlled room with 12 h oflight daily. Food
and water were given ad libitum. Suspensions
ofMT-W9B mammary adenocarcinoma (Kim
and Depowski, 1975) were prepared for
transplantation with a Snell cytosieve, as
previously described (Clifton and Draper,
1963), and were adjusted to a 330o volume of
centrifugally packed cell material. Inocula of
0.10 ml of tumour suspension were injected
into both irradiated axillary mammary
glands, and 12 and 18 days later similar
inocula were injected into the right un-
irradiated inguinal mammary gland. The
axillary mammary glands were injected with
tumour tissue 1-1 5 months after exposure to
1500 R X-rays.
Irradiation procedure.-Before irradiation
the animals were anaesthetized by i.p.
injection of 20 mg of ketamine HCI (Ketalar,
Parke Davis). They were taped to a board,
ventral side up, and a 4mm lead shield was
placed in such a way that only the thoracic
region, excluding the oesophagus, was irradi-
ated. The skin of the unshielded areas was
exposed to 1500 R X-rays at a rate of 256
R/min, whereas the shielded areas received
less than 5%/O ofthe total exposure. A General
Electric Maxitron 250 unit, operated at 250
kVp and 30 mA with a 1 0 mm Al filter, was
used throughout. All animals survived the
initial irradiation procedure and were alive
for the duration of the experiment (2-2-5
months).
Blood-flow estimation.-Full details and the
rationale for the use of this procedure are
provided elsewhere (Jirtle et al., 1978a) and it
will be briefly described here. When the
tumours reached the desired size, the rats
were surgically prepared under ether anaes-
thesia. Catheters filled with heparinized saline
were placed into both the left ventricle of the
heart and the left femoral artery. They were
tied off, placed s.c. and exteriorized at the
dorsal aspect of the neck. All animals were
returned to individual cages and allowed to
recover for at least 3 h before the micro-
spheres were injected.
To estimate the control blood flows,
-70,000 microspheres 25 um in diameter,
labelled with either l09Cd or 46SeC, were
slowly fed into the left ventricle of the heart
with 0-6 ml of isotonic saline. An integral
arterial blood sample was withdrawn during
and for 1 min after the spheres were injected,
and then flushed into a wide-mouthed y-ray-
counting vial.
To determine the response of normal and
malignant tissue to vasoactive drugs, a 0*10
ml bolus of either 5 Hug or noradrenaline, 1 ,ug
of angiotensin II, or 1 ,ug of isoprenaline was
injected into the left ventricle. Microspheres
25 Hum in diameter, and labelled with a
different nuelide from those initially used,
were injected 0-75 min later. Blood was
simultaneously withdrawn as previously des-
cribed and after completion the animals were
killed with intracardiac injections of a
euthanasia solution (Vet Labs, Lenexa, KS).
Skin, tumours and mammary-gland tissue
were removed from both the axillary and the
right inguinal regions, dissected free of
surrounding extraneous tissue, weighed and
placed in y-ray-counting vials. For each
tissue sample, the two isotope activities and
the corresponding number of spheres were
determined by appropriate data reduction of
the output from a 3-channel Nal well counter
equipped with pulse-height analysers (Rankin
and Phernetton, 1976).
The blood flow to various tissues was
calculated from the formula: FT = (WR/
NB) X (NT), where FT is the tissue blood
flow (ml/min/g), WR is the rate of arterial-
blood sample withdrawal (ml/min), NB
is the number of microspheres in the
withdrawn blood sample, and NT is the
average number of microspheres per gram of
tissue. The systemic arterial blood pressure
was measured with a Statham pressure
transducer and was continuously recorded,
except when an arterial blood sample was
being withdrawn. The resistance to tissue
blood flowr was calculated by the formula:
RT = Pa/FT where RT is the resistance to
tissue blood flow (mmHg/ml/min/g) and Pa is
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the average systemic arterial pressure. The
value of Pa was estimated by linear inter-
polation of the recorded pressure data. The
resistance to blood flow aftertheinjectionofa
vasoactive drug divided by that before (i.e.
treated/control) will be referred to as the
resistance ratio, as it expresses the fractional
change in blood-flow resistance. Thus, if saline
is injected rather than vasoactive drugs, the
resistance ratios should theoretically be 1-0.
However, with this animal system, the
resistance ratios forskin, mammarygland and
tumours were previously determined to be
1-61, 1-60 and 1P90 respectively (Jirtle et al.,
1978a).
Statistical analysis.-Since the resistance
ratios and blood-flow data are adequately
described by a log normal distribution (Jirtle
et al., 1978a, b), all parametric statistical tests
were performed on natural logarithmically
transformed data. The paired t test was used
to compare the resistance ratios in unirradia-
ted tissue to that in preirradiated tissue, and
to compare the resistance ratios of tumours
growing in either unirradiated or preirradi-
ated mammary-gland tissue. The two-sample
t test assuming unequal variances was used for
all other comparisons of means. The extent
of the association between the relative blood
flow to tumours in preirradiated mammary
tissue and the tumour weight was estimated
bythe linear correlation coefficient (Brownlee,
1965).
Drugs.-Noradrenaline (Levophed bitar-
trate, Winthrop Labs), angiotensin II (Bach-
em, Inc.) and isoprenaline (Isuprel hydro-
chloride, Winthrop Labs) were diluted to the
appropriate concentrations in isotonic saline,
and were always stored in the frozen state to
minimize deterioration.
RESULTS
Preirradiation of the thoracic region
with 1500 R X-rays did not significantly
increase the systemic arterial pressure
(102-6J2-0, for 37 rats) from the control
value of 96-8 mmHg (P = 0-10; Jirtle et
al., 1978a). The blood flow to the axillary
mammary glands significantly increased
(P = 0-01) from 0-106 ml/min/g (95%
confidence interval, 0-082-0-138, for 12
rats) to 0-256 ml/min/g (95% confidence
interval, 0-218-0-301, for 37 rats). The
increase in the average blood flow to the
irradiated skini from 0-278 ml/min/g (95%
confidenceinterval,0-233-0-333, for12rats)
to 0-343 ml/min/g (95% confidence inlterval
0-298-0-396, for 37 rats) was not, how-
ever, significant (P= 0-10). Thus, irra-
diation of normal tissue ,--2 months
before blood-flow estimation either in-
creased or caused no significant change
in theaverage tissue blood flow.
In contrast, the average blood flow to
tumoursinpreirradiatedaxillarymammary
gland was 52±5% (9 observations) that of
equivalent-sized tumours in unirradiated
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FIG. 1.-Blood flow of tumours (per g tissue)
growing in either unirradiated (0) or pre-
irradiated (1500 R X-rays, 0) mammary
gland plotted against tumour weight. The
standarderrorsof the means are shown and
the number ofobservations at each point is
in parenthesis.
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FiG. 2.-Tumour weight against time after
the injection of 0-10 ml of a 33% tumour
suspension into unirradiated (r01) or pre-
irradiated (1500 R X-rays, 0) mammary
gland. The closed symbols (-, 0) repre-
sent weights estimated from the tumour
diameter, assuming its spherical shape.
Standard errors of the means are shown
and the number of observations at each
point is in parenthesis.
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TABLE-The Response of Irradiated Normal Tissues and Tumours in Preirradiated
Mammary Glands to Vasoactive Drugs, Expressed as Resistance Ratioa
Tissue
Mammary gland
Unirradiated
1500 R
Skin
Unirradiated
1500 R
Tumour in Unirradiated
Mammary gland
1500R
5 ug Noradrenaline
Number of
Specimensb
7 26.6(14.6-48-2)
7 23-7(13-6-41-5)
7 6 9(44-10 8)
7 11.3(9.2-13 8)
7 23.8(12.5-45.4)
14 21 3(144-315)
1 ,g Angiotensin II
Number of
Specimensc
13 55 5(38 1-80 7)
13 26 0(18 5-36 6)
13 15.9(12 1-21.1)
13 17 6(12 9-23.9)
8 3.6(2 2-6 5)
26 4.1(3 2-5 2)
1 ltg Isoprenaline
Number of
Specimensc
10 1 2(10-1 6)
10 0-7(0-5-1-1)
10 1.2(0 9-1 7)
10 1-6(12 2-23)
9 1 4(1 2-1-8)
18 1 7(1 3-22)
a Second estimate/first estimate. Values in parentheses are 95% confidence limits.
b No. animals = 7
C No. animals = 13
d No. animals = 10
host tissue (Fig. 1). As with tumours in
unirradiated mammary tissue (Jirtle et al.,
1978a) blood flow significantly decreased
with increasing tumour size (P<0.001,
Fig. 1). As expected, tumours in pre-
irradiated sites grew at a slower rate than
those in unirradiated tissue (e.g. it took 33
days for a tumour growing in a preirradia-
ted site to reach a weight attained in '19
days by those growing in unirradiated
tissue (Fig. 2)).
Irradiated and unirradiated skin had
similar resistance ratios after the injection
of either noradrenaline or angiotensin II
(P - 0-10, Table). In contrast to un-
irradiated skin, irradiated skin was un-
responsive to a bolus injection of 1 ug of
isoprenaline (P 0 10). Theirradiated and
unirradiated mammary glands also res-
ponded in a similar manner to the injection
of 5 ,ug of noradrenaline (P> 0 10). How-
ever, the vasculature in irradiated mam-
mary gland was more sensitive to the
injection ofisoprenaline, and less sensitive
to the injection of 1 ,ug of angiotensin II
(P = 0-01). Tumours growing in unirradi-
ated and preirradiated mammary gland
tissue responded similarly to the 3 vaso-
active drugs tested (P - 0-10).
DISCUSSION
Our results show that: (a) the bloodflow
to irradiated mammary glands increased 2
months after exposure, but that to
irradiated skin remained unchanged; (b)
the blood flow to tumours in preirradiated
mammary glands was halfthat to tumours
of equal weight in unirradiated tissue; (c)
the exposure of mammary-gland tissue
and skin to radiation altered their res-
ponse to some vasoactive drugs; and (d)
the changes in resistance to tumour blood
flow elicited by the injection of the 3
vasoactive drugs studied were not altered
by preirradiation of the graft site. Thus
the effect ofradiation on tissue blood flow,
and changes in resistance in response to
vasoactive agents, are both partly depen-
dent on the tissue irradiated.
Even though the average blood flow to
the mammary gland was increased after
irradiation, it does not necessarily follow
that capillary blood flow was also increas-
ed. If the smooth muscle which controls
the blood flow through arteriovenous
shunts is severely damaged by radiation, a
greater proportion of the total blood flow
could be shunted around the tissue
capillary bed. In such a case, capillary
blood flow might actually be decreased,
even though the total flow to the tissue is
increased. The effect that the dilatation of
irradiated vessels, described by Lindop
et al. (1970) and Takahashi and Kallman
(1977) has on the capillary blood flow
remains unclear. However, the tissue
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damage which becomes apparent several
months after irradiation, if dependent
upon blood flow, is probablv more closely
correlated to alterations in capillary blood
flow than to changes in total tissue blood
flow.
The reduction in tumour growth rate as
a result of the TBE has been postulated to
be primarily due to an inhibition of the
ability of irradiated capillaries to develop
rapidly enough to supply oxygen and
nutrients to the tumour (Summers et al.,
1964; Clifton and Jirtle, 1975). Our data
demonstrate that thebloodflowtotumours
in preirradiated tissue is significantly
lower than that to tumours of equivalent
size in unirradiated tissue. Since a larger
fraction of a tumour in preirradiated host
tissue is comprised of necrotic regions,
some of the observed reduction in the
relative blood flow must be due to the
inclusioni of relatively avascular necrotic
areas. Because the tumours in this study
could not be easily separated into grossly
"viable" and necrotic regions, it was not,
however, possible to determine whether
the observed reduction in tumour blood
flow was entirely attributable to inclusion
of necrotic avascular areas, or was in part
due to a reduction in flow to "viable"
tumour tissue.
Moss and Gold (1963) observed that the
response of vessels in the hind limb to
acetyleholine was decreased 4 to 6 weeks
after 3000 R X-rays. In addition, irradia-
ted hind limbs (4000-7000 R) displayed a
progressive inability to mount a hyperae-
mic response after ischaemia by tourniquet
(Horn et al., 1974). Both results imply that
irradiated normal tissue has a reduced
ability to increase blood flow. Since Horn
et al. (1974) and Moss and Gold (1963) both
measured the response of an entire hind
limb, it is difficult to compare their results
to our measurements of the response of
individual tissues. We have found that the
ability of irradiated tissue to increase
blood flow in response to isoprenaline is
tissue-dependent (i.e., irradiation increas-
ed the response ofthe mammary gland but
decreased the response ofskin).
We have suggested (Jirtle et al., 1978b)
that angiotensin II might be used in
conjunction with radio-opaque material to
enhance the radiographic imaging of
mammary tumours. It has recently been
reported that radiotherapy of mammary
tumours is as effective as more radical
treatment modalities (Spitalier et al.,
1977). Tumours which recur after such
therapy will be growing in previously
irradiated host tissue. Assumingourresults
are indicative of the human situation, the
total blood flow to the mammary gland
about 2 months after irradiation would be
greater than that in unirradiated mam-
mary tissue. In contrast, the average
blood flow to the recurrent tumour would
be less than that to a primary tumour of
equal size. This implies that the difference
between normal and malignant tissue
blood flow would be less for a recurrent
tumour than for a primary tumour, and
that radiographic imaging would thus be
impaired. Thus a method to improve the
imaging ofrecurrent tumours in irradiated
mammary gland may well be particularly
useful in suspected recurrence.
Our data demonstrate that, though
irradiated mammary tissue is less respons-
ive to angiotensin II than the unirradiated
mammary gland, the response is still 6
times that for the tumour. We therefore
suggest that the infusion of angiotensin II
may improve the imaging of tumours in
irradiated as well as in unirradiated mam-
mary gland tissue.
During these studies, we found that
irradiated animals were uniquely sensitive
to the action of vasoconstricting drugs.
Doses of noradrenaline and angiotensin II
which did not kill normal animals (i.e. a
bolus injection of 20jig) killed every
preirradiated animal. The maximum doses
of noradrenaline and angiotensin II
which could be used with minimum
complications were 5 and 1 pig, respective-
ly. At necropsy the lungs of these irradia-
ted animals were found to be hyper-
inflated. This suggests impairment of
expiration, possibly caused by fluid ac-
cumulated in the bronchioles. Histological
10)371038 R. JIRTLE, J. H. G. RANKIN AND K. H. CLIFTON
sections ofthe lungs showed acute haemor-
rhages into the alveolar spaces. Thus it is
postulated that the lung vasculature was
damaged by the radiation, but that this
damage was manifested only when the
systemic arterial pressure was suddenly
increased by a bolus injection of a drug
causing systemic vasoconstriction. Similar-
ly, Blomstrand, Johansson and Rosengren
(1974) observed an increased vulnerability
of cerebral vessels to acute blood-pressure
increases after exposure to 3000 R X-rays.
Vasoconstricting drugs should thus be
used withcaution, andhypertensionshould
be carefully controlled in patients whose
lungs have previously been irradiated.
We are indebted to Ms Joan Eggert for excellent
technical assistance. This work was supported in
part by the American Cancer Society Grant PDT-
46R and by NIH and NCI Grant CA18756.
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